Pfizer Increases Warning on Bextra Skin Risk
528016
Pfizer Inc. on Friday said two clinical trials showed patients taking its anti-inflammatory drug Bextra had a higher risk of cardiovascular events during high-risk coronary bypass surgery.
665144
More evidence of how painkillers called COX-2 inhibitors can raise the risk of heart disease was published Monday, showing Pfizer Inc.'s Bextra can triple the risk of heart attack and stroke in certain patients.
443157
U.S. health officials Thursday called on doctors to limit prescribing Pfizer Inc. painkillers Celebrex and Bextra in light of recent evidence that they may increase the risk of heart attack and stroke.
21205
WASHINGTON, Dec 23  - US regulators called Thursday for use of Pfizer&#39;s painkilling drugs Celebrex and Bextra to be limited, urging doctors to keep in mind indications of higher heart attack and stroke risks.
626420
Pfizer Inc. said on Wednesday that a  report in The New York Times draws "unsubstantiated  conclusions" about the safety of its painkiller Bextra.
181893
The U.S. Food and Drug  Administration on Thursday ordered the review of preventative  studies involving Pfizer Inc.'s painkillers Celebrex and  Bextra, in light of recent evidence they may increase the risk  of heart attack and stroke.
566352
U.S. regulators on Friday said Pfizer Inc's anti-smoking drug Chantix appears increasingly likely to be linked to serious psychiatric behavior, and called for stronger label warnings.
80442
The US Food and Drug Administration on Thursday ordered the review of preventative studies involving Pfizer Inc.&#39;s painkillers Celebrex and Bextra, in light of recent evidence they may increase the risk of heart attack and stroke.
132323
The new warning states that Bextra should not be used in patients undergoing heart bypass surgery. In October, Bextra&#39;s manufacturer, Pfizer, announced results of a study showing an increase in heart problems in patients having heart bypass surgery.
365287
Kaiser Permanente has stopped dispensing Bextra, an arthritis and pain drug made by Pfizer that may increase the risk of heart attacks and strokes.
254416
U.S. regulators should pull Pfizer  Inc.'s arthritis drugs Celebrex and Bextra from the market  because they are too risky, U.S. consumer watchdog group Public  Citizen said in a letter on Monday.
80575
Drugmaker Pfizer Inc. is in talks with  regulators over a likely change to arthritis drug Bextra's  label to carry the strictest possible warning alerting doctors  of the risk of a potentially deadly skin reaction, the company  said in a regulatory filing.
553899
U.S. regulators should pull Pfizer Inc.'s arthritis drugs Celebrex and Bextra from the market because they are too risky, U.S. consumer watchdog group Public Citizen said in a letter on Monday.
588963
Bayer AG and Onyx Pharmaceutical Inc.'s  key cancer drug Nexavar significantly raises the risk of high  blood pressure, U.S. researchers said on Tuesday.
586119
The FDA has just changed the warning label on the pain reliever Bextra to emphasize the risk of a rare but potentially fatal &quot;skin reaction,&quot; Stevens-Johnson syndrome.
224819
The U.S. Food and Drug Administration has warned Pfizer Inc.  that television and print advertisements for its painkillers Celebrex and Bextra misled consumers, according to a letter made public on Wednesday.
270075
A new study showing an increased risk of blood clots among women using a contraceptive skin patch prompted the Food and Drug Administration on Friday to add that finding to the drug's label.